Skip to main content
Premium Trial:

Request an Annual Quote

Not in the Know


A recent study in the journal Cancer found that while women with an average risk of developing breast cancer are getting the recommended advice about their cancer susceptibility, less than half of women at high risk for breast cancer are getting the information they need, reports Medscape Medical News' Jim Kling. Physicians informed 71 percent of women at average risk about their possible BRCA1 and BRCA2 mutations, but only informed 41 percent of women at high risk, the study found. The researchers conducted a survey of 3,200 family physicians, general internists, and OB-GYNs, 62 percent of whom responded, Kling says. One problem, the authors found, is that high-risk women may not be correctly identified. "Correct identification of high-risk women was a strong predictor of counseling and testing referral," Kling says. "Physicians who identified high-risk women were 8.46 times more likely to make a referral than physicians who misidentified high-risk women as average risk." The authors of the study write that efforts are needed to encourage doctors to recommend appropriate counseling and testing for high-risk women, while simultaneous efforts are needed to discourage such testing and counseling for average-risk women.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.